We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $8.34B
1-Year Est. Return 46.58%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+46.58%
3 Year Est. Return
+191.6%
5 Year Est. Return
+200.35%
10 Year Est. Return
+3,561.44%
AUM
$7.98B
AUM Growth
-$21.8M
Cap. Flow
-$149M
Cap. Flow %
-1.86%
Top 10 Hldgs %
34.31%
Holding
287
New
30
Increased
70
Reduced
150
Closed
36

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$82.6M
2
EMBJ
Embraer S.A. ADS
EMBJ
+$56.2M
3
TBBB icon
BBB Foods
TBBB
+$39.9M
4
NTRA icon
Natera
NTRA
+$35.9M
5
LOAR icon
Loar Holdings
LOAR
+$29.9M

Sector Composition

Rank Sector Weight
1 Technology 31.65%
2 Consumer Discretionary 19.21%
3 Healthcare 16.85%
4 Communication Services 13.51%
5 Industrials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCUS icon
176
Arcus Biosciences
RCUS
$3.47B
$2.1M 0.03%
138,027
-36,628
-21% -$591K
CMG icon
177
Chipotle Mexican Grill
CMG
$47.5B
$2.07M 0.03%
32,993
-1,607
-5% -$99.8K
PODD icon
178
Insulet
PODD
$11.8B
$2.04M 0.03%
10,122
+2,808
+38% +$506K
SRPT icon
179
Sarepta Therapeutics
SRPT
$1.68B
$1.98M 0.02%
12,502
-4,692
-27% -$603K
WSO icon
180
Watsco Inc
WSO
$13.1B
$1.97M 0.02%
4,256
+18
+0.4% +$8.23K
VEEV icon
181
Veeva Systems
VEEV
$33.5B
$1.94M 0.02%
10,600
-216
-2% -$42.9K
UBER icon
182
Uber
UBER
$146B
$1.92M 0.02%
26,438
-18,777
-42% -$1.31M
PHR icon
183
Phreesia
PHR
$698M
$1.8M 0.02%
+85,088
New +$1.85M
BRK.B icon
184
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.8M 0.02%
4,423
+99
+2% +$40.5K
GDRX icon
185
GoodRx Holdings
GDRX
$1.07B
$1.77M 0.02%
226,787
+2,473
+1% +$18.3K
DASH icon
186
DoorDash
DASH
$87.4B
$1.76M 0.02%
16,141
-55
-0.3% -$6.63K
ARGX icon
187
argenx
ARGX
$52B
$1.65M 0.02%
3,833
-68
-2% -$26K
PLGO
188
Pelagos Insurance Capital
PLGO
$2.16B
$1.57M 0.02%
96,427
-120,304
-56% -$2.13M
EXE
189
Expand Energy Corp
EXE
$21.9B
$1.29M 0.02%
15,736
-17,979
-53% -$1.59M
BILL icon
190
BILL Holdings
BILL
$4.7B
$1.28M 0.02%
24,370
+3,869
+19% +$219K
BLZE icon
191
Backblaze
BLZE
$936M
$1.28M 0.02%
207,908
-11,748
-5% -$91.6K
PCVX icon
192
Vaxcyte
PCVX
$7.73B
$1.27M 0.02%
16,831
-247
-1% -$16.8K
BRZE icon
193
Braze
BRZE
$2.89B
$1.26M 0.02%
32,488
+1,846
+6% +$73.7K
ALAB icon
194
Astera Labs
ALAB
$55B
$1.26M 0.02%
+20,850
New +$1.45M
APLD icon
195
Applied Digital
APLD
$8.49B
$1.26M 0.02%
+211,547
New +$821K
AFRM icon
196
Affirm
AFRM
$25.3B
$1.24M 0.02%
41,120
+2,506
+6% +$80.4K
RUN icon
197
Sunrun
RUN
$2.49B
$1.24M 0.02%
104,404
-787
-0.7% -$9.64K
STOK icon
198
Stoke Therapeutics
STOK
$1.84B
$1.2M 0.02%
88,577
-1,206
-1% -$16.3K
XOM icon
199
ExxonMobil
XOM
$643B
$1.15M 0.01%
10,011
-16,514
-62% -$1.92M
BBIO icon
200
BridgeBio Pharma
BBIO
$15.7B
$1.12M 0.01%
44,302
-997
-2% -$27.3K

Similar funds

Gilder Gagnon Howe & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Gilder Gagnon Howe & Co held 287 positions worth $7.98B, down 0.27% from $8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Gilder Gagnon Howe & Co's Q2 2024 filing shows 30 new, 70 increased, 150 reduced and 36 closed positions. Its largest new stake was Boston Scientific: 1,128,740 shares worth $86.9M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Gilder Gagnon Howe & Co's largest Q2 2024 buy was Boston Scientific: 1,128,740 shares worth $86.9M.
  • Gilder Gagnon Howe & Co added most to BBB Foods in Q2 2024, an estimated $39.9M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $107M.
  • Gilder Gagnon Howe & Co fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $171M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 34% of its $7.98B portfolio in Q2 2024.
  • Gilder Gagnon Howe & Co opened 30 new positions and closed 36 in Q2 2024.
  • Gilder Gagnon Howe & Co's portfolio value fell 0.27% quarter-over-quarter to $7.98B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2024, filed 14 Aug 2024.